Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityOther Non-Current LiabilitiesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Payables (2021)

Goldenwell Biotech filings provide 1 years of Payables readings, the most recent being $111488.0 for Q4 2021.

  • On a quarterly basis, Payables changed N/A to $111488.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $111488.0, a N/A change, with the full-year FY2021 number at $111488.0, changed N/A from a year prior.
  • Payables hit $111488.0 in Q4 2021 for Goldenwell Biotech, up from $103125.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $111488.0 in Q4 2021 to a low of $103125.0 in Q2 2021.